[Hub]/) : Traits : Leg fat percentage (left) : ← →

chr8:86,841,229-88,271,452

Best TWAS P=2.86e-10 · Best GWAS P=3.24e-10 conditioned to 0.0889

Associated models

#	Study	Tissue	Gene	h2	eQTL R2	model	# weights	model R2	model R2 P	eQTL GWAS Z	TWAS Z	TWAS P	Top SNP corr	PP3	PP4	joint
16	The Cancer Genome Atlas	Soft Tissue Sarcoma	FAM82B	0.07	0.00	blup	45	0.01	1.1e-01	-6.3	6.3	2.9e-10	-0.86	0.00	0.66	TRUE
14	The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	WWP1	0.03	0.01	blup	63	0.02	1.8e-03	-5.7	-6.0	1.5e-09	0.92	0.03	0.91	FALSE
2	GTEx	Artery Tibial	RMDN1	0.18	0.08	lasso	9	0.10	1.8e-08	-6.0	5.9	3.1e-09	-0.95	0.01	0.99	FALSE
6	GTEx	Cells Transformed fibroblasts	NTAN1P2	0.07	0.02	lasso	6	0.03	2.0e-03	-6.0	5.9	3.4e-09	-0.84	0.01	0.98	FALSE
3	GTEx	Brain Cerebellum	NTAN1P2	0.19	0.14	enet	11	0.10	6.0e-04	-5.8	-5.8	6.5e-09	0.90	0.02	0.95	FALSE
10	GTEx	Stomach	RMDN1	0.15	0.05	lasso	6	0.06	1.2e-03	-6.3	5.7	1.2e-08	-0.88	0.01	0.97	FALSE
15	The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	WWP1	0.05	0.01	enet	8	0.02	2.0e-02	5.5	-5.7	1.3e-08	0.80	0.02	0.60	FALSE
13	The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	CPNE3	0.07	0.03	lasso	4	0.05	2.3e-06	-6.0	-5.7	1.5e-08	0.82	0.00	0.99	FALSE
1	CommonMind	Brain Pre-frontal Cortex	CPNE3	0.17	0.07	blup	453	0.10	7.9e-12	4.2	-5.6	2.9e-08	0.59	0.20	0.80	FALSE
8	GTEx	Skin Sun Exposed Lower leg	RMDN1	0.05	0.04	lasso	2	0.01	1.1e-01	5.5	5.5	4.7e-08	-0.80	0.07	0.87	FALSE
9	GTEx	Spleen	RMDN1	0.46	0.20	enet	29	0.18	2.2e-05	-6.3	5.4	5.1e-08	-0.83	0.02	0.97	FALSE
7	GTEx	Skin Not Sun Exposed Suprapubic	RMDN1	0.22	0.07	lasso	7	0.11	1.9e-06	5.1	5.4	7.3e-08	-0.82	0.05	0.93	FALSE
5	GTEx	Cells Transformed fibroblasts	RMDN1	0.27	0.15	enet	30	0.23	1.5e-17	3.0	5.3	9.7e-08	-0.81	0.17	0.83	FALSE
4	GTEx	Cells Transformed fibroblasts	WWP1	0.06	0.00	lasso	6	0.00	1.5e-01	5.5	-5.3	1.1e-07	0.71	0.13	0.14	FALSE
12	YFS	Blood	WWP1	0.09	0.06	blup	457	0.09	1.3e-26	5.1	-5.2	2.1e-07	0.77	0.08	0.92	FALSE
11	NTR	Blood	CPNE3	0.02	0.01	blup	451	0.01	2.1e-03	1.6	-5.1	2.9e-07	0.48	0.27	0.22	FALSE